LPCN
Lipocine Inc.
NASDAQ · USHealthcareBiotechnology
$2.21-0.90%
Price as of Jul 20, 2026
LPCN earnings
Lipocine Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 4, 2026in NaN days
EPS est $-0.40 · Revenue est $213000
Track record
Beat EPS in 6 of 12 quarters
Avg surprise +8.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-0.51 | $-0.54 | -5.9% | $1M | +634.8% |
| Mar 9, 2026 | $-0.61 | $-0.34 | +44.3% | $1M | +887.4% |
| Nov 6, 2025 | $-0.56 | $-0.59 | -5.4% | $114574 | -51.9% |
| May 8, 2025 | $-0.35 | $-0.35 | +0.0% | $93864 | -73.3% |
| Mar 13, 2025 | $-0.40 | $0.33 | +182.5% | $3M | +33.6% |
| Nov 7, 2024 | $-0.48 | $-0.44 | +8.3% | — | — |
| Aug 8, 2024 | $-0.78 | $-0.56 | +28.2% | $89565 | -69.1% |
| May 9, 2024 | $-0.68 | $0.66 | +197.1% | $8M | — |
| Mar 7, 2024 | $-0.53 | $-0.42 | +20.8% | $216188 | — |
| Nov 8, 2023 | $-0.57 | $-1.27 | -122.8% | $-3M | -1116.9% |
| Aug 10, 2023 | $-0.64 | $-0.68 | -6.3% | — | — |
| May 11, 2023 | $-0.42 | $-0.68 | -61.9% | $54990 | -93.0% |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-04.